Trial Profile
Prospective study of teleprevir based triple therapy in chronic hepatitis C genotype 1b patients with the IL28B minor genotype.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Nov 2015 New trial record